The FASEB Journal, Vol 4, 2646-2651, Copyright © 1990 by The Federation of American Societies for Experimental Biology

REVIEWS

Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE

Y Shoenfeld and E Mozes
Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.

Systemic lupus erythematosus (SLE) is considered a classical autoimmune disease that involves many biological systems. Similar to other autoimmune conditions, its etiology is multifactorial entailing genetic, environmental, hormonal, and immunologic factors. In this review we demonstrate that by using a pathogenic idiotype of anti-DNA autoantibodies, it is possible to explain some of the pathogenesis and diversity of clinical and serological manifestations reported by SLE patients. The 16/6 idiotype (Id) is a representative pathogenic idiotype of anti-DNA autoantibodies. The serum titers of 16/6 Id in SLE patients correlate with clinical activity of the disease, and are deposited in afflicted tissues in SLE patients. SLE was experimentally induced in naive mice after immunization with 1 microgram of the Id. The disease is characterized clinically (proteinuria), serologically (e.g., anti-dsDNA, anti-Sm antibodies), and by pathological findings (e.g., deposition of 16/6 Id in the kidneys). The condition can be induced by other human and mouse antibodies carrying the 16/6 Id, as well as by mouse antimonoclonal-16/6 Id and by T cell lines and clones specifically reactive with 16/6 Id. There are strain-dependent differences in susceptibility to the induction of systemic lupus erythematosus (SLE). Induction of SLE is directly correlated with the ability to respond to the 16/6 idiotype (or 16/6 Id)2 by anti-Id antibody production. It is easier to induce the disease in females, and it can be modulated by manipulation of sex hormones. Being able to identify the pathogenic idiotype allowed us to generate T suppressor (Ts) cells specific for the 16/6 Id. Treatment of mice with these T cells abrogated the disease. Our studies point to the importance of pathogenic idiotypes of autoantibodies in autoimmunity, which suggests that SLE may represent a dysregulation of a functional network of idiotypes-anti-idiotypes interactions among autoreactive B cells, T helper cells, and T suppressor cells.

This article has been cited by other articles:

				M. Blank and Y. Shoenfeld Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus Rheumatology, September 1, 2005; 44(9): 1086 - 1089. [Full Text] [PDF]

				J K Kalsi, J Grossman, J Kim, P Sieling, D W Gjertson, E F Reed, F M Ebling, M Linker-Israeli, and B H Hahn Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration Lupus, July 1, 2004; 13(7): 490 - 500. [Abstract] [PDF]

				M Ehrenfeld, M Blank, Y Shoenfeld, and M Hidvegi AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease Lupus, September 1, 2001; 10(9): 622 - 627. [Abstract] [PDF]

				P. A. Sieling, S. A. Porcelli, B. T. Duong, F. Spada, B. R. Bloom, B. Diamond, and B. H. Hahn Human Double-Negative T Cells in Systemic Lupus Erythematosus Provide Help for IgG and Are Restricted by CD1c J. Immunol., November 1, 2000; 165(9): 5338 - 5344. [Abstract] [Full Text] [PDF]

				Y Shoenfeld Eppur si muove (Galileo Galilei 1564-1642): the idiotypic dysregulation of autoantibodies as part of the etiology of SLE Lupus, September 1, 2000; 9(7): 481 - 483. [PDF]

				F Satake, N Watanabe, N Miyasaka, Y Kanai, and T Kubota Induction of anti-DNA antibodies by immunization with anti-DNA antibodies: mechanism and characterization Lupus, September 1, 2000; 9(7): 489 - 497. [Abstract] [PDF]

				A. Waisman, P. J. Ruiz, E. Israeli, E. Eilat, S. Konen-Waisman, H. Zinger, M. Dayan, and E. Mozes Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody PNAS, April 29, 1997; 94(9): 4620 - 4625. [Abstract] [Full Text] [PDF]

				G. Villarreal, C. Drenkard, A. Villa, H. Slor, S. Shafrir, R. Bakimer, Y. Shoenfeld, and D. Alarcon-Segovia Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity Lupus, January 1, 1997; 6(5): 425 - 435. [Abstract] [PDF]

				Y. Shoenfeld, I. Krause, and M. Blank New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation Ann Rheum Dis, January 1, 1997; 56(1): 5 - 11. [Abstract] [Full Text]

				N. Zurgil, R. Bakimer, A. Tincani, D. Faden, J. Cohen, M. Lorber, G. Valesini, and Y. Shoenfeld Detection of Anti-Phospholipid and Anti-DNA Antibodies and their Idiotypes in Newborns of Mothers with Anti-Phospholipid Syndrome and SLE Lupus, August 1, 1993; 2(4): 233 - 237. [Abstract] [PDF]